The Curaleaf Inhalation Device
At Curaleaf International, in partnership with Jupiter Research, we have developed Europe’s first handheld liquid inhalation device — offering precision, safety, and ease of use for medical cannabis dosing.
The Curaleaf Inhalation Device is the first handheld liquid device ever to earn EU Class IIa medical‑device certification.
Every unit has passed the safety, performance and biocompatibility tests in line with European Pharmacopoeia. This patient-friendly, compact, and discreet device is designed with precision in mind, giving prescribers confidence in this controlled delivery system.
A new inhalation standard
This sleek, pocket sized medical device represents an innovation in inhalation of liquid cannabis formulations, enabling discreet use and ensuring a standardised dose with every puff.
CCELL SE Atomizer Platform
Designed to deliver consistent and smooth vapour through its innovative porous ceramic heating element.
Integrity & Hygiene for Users
The cartridge becomes tamper-resistant and non-refillable once inserted into the mouth piece - ensuring reliable, single-patient use.
Disposable Mouthpiece & Cartridge
Engineered for optimal comfort during use, enhancing the overall user experience.
User-friendly Operation
The device automatically activates when detecting negative pressure from inhalation, making it easy and intuitive to use.
The device is calibrated for a puff duration of 3 seconds.
USB-C Compatible
Unlike traditional disposable vapourisers, the Medical Inhaler Device is rechargeable via USB-C, offering extended usability and reducing environmental waste.
Global‑Market Availability
CE‑marked for all EU member states (plus UK, Switzerland, Canada, Australasia), get in touch with the team to understand the availability in your market.